The next stage of revalidation is coming, here are some vital tools to help you prepare.
MMR: Winning the battle for hearts and mindsSubscription
Community pharmacy is in a prime position to help refute damaging anti-vaccination myths and, as a direct result, could save lives.
While Brexit may not be the direct cause of worsening medicines shortages, it is distracting Westminster from giving the issue the attention it needs.
A street drug-testing pilot scheme in Somerset suggests that pharmacists could have a massive impact on reducing illicit drug use, but this work will go no further if funding is not found.
The warning lights are flashing, but 2019 could mark a turning point.
The pharmacy regulator must be more transparent about how it conducts fitness-to-practise investigations if trust in its ability to do a fair job is to be maintained.
Pharmacists supporting patients to appropriately treat sudden, short bouts of pain through self-care will put patients at the centre of their treatment.
It is understandable that pharmacists are reluctant to buy expensive equipment and change their workflows to comply with the Falsified Medicines Directive when the legislation may no longer apply after Brexit.
In January 2019, Boots announced that it was changing the way it dispenses medicines to care homes — from multicompartment compliance aids to original packs.
Much can be done to improve the quality of life for patients presenting to their community pharmacy with joint pain.
Cuts to preregistration placement funding threaten to undo all the progress that has been made across pharmacy in recent years.
Although the ‘NHS Long-Term Plan’ outlines some potential new roles for pharmacists, the lack of detail on plans for community pharmacy are cause for concern.